Weight-loss, diabetes drugs linked to vision problems in small study
Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study at the University of British Columbia. Some common GLP-1 drugs include Ozempic and Wegovy, which contain semaglutide…
